FDA has granted AWAK Technologies a breakthrough device designation for a wearable and ultra-portable peritoneal dialysis device.
The MD&M West Conference Feb. 5-7 in Anaheim, CA will feature a curated roster of speakers with deeply-technical expertise in everything from new technology and next-generation design, to product development, new materials, product testing, and quality.
Key changes include sections guiding education and marketing programs, communication on safe and effective use of medtech, and on providing technical support. The update also expands provisions on support for third-party educational and other conferences.
Each year the J.P. Morgan Healthcare Conference serves as the start of medtech’s season. Now that it has ended, here are 7 key things we learned about companies presenting during the event.
The San Clemente, CA-based firm is developing several glaucoma treatment products as it transitions into a hybrid surgical, pharmaceutical, and medical device company.
The San Diego-based company presented at the 37th annual J.P. Morgan Healthcare Conference and said its revenue increased by 43% in 2018 despite mounting competition from rivals.
Google’s former life sciences division said it would use the proceeds from the $1 billion investment round to help with its collaborations and potential acquisitions.
The company that developed the AngelMed implantable cardiac monitor system has filed for Chapter 11 bankruptcy.
Oculogica's concussion test takes some of the guesswork out of concussion assessment and does not require a baseline measurement for comparison.
A recently-published meta-analysis showed higher mortality rates with Paclitaxel drug-coated balloons and drug-eluting stents, and at least two drug-eluting device trials have been paused.
FDA’s nod for the Sapien 3 Ultra valve comes at a time when the TAVR market is heating up with competition.